Skip to main content
SpringerLink
Log in

Leptin after IGF-I Generation Test in a Patient with Hypopituitarism and Myotonic Dystrophy Disease

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

A 54-years-old woman diagnosed of myotonic dystrophy (MyD) with past medical history of massive post-partum haemorrhage at age 28 and panhypopituitarism was studied. BMI and body composition were determined and we determined baseline serum IGF-I, IGFBP3, insulin and leptin levels and after the IGF-I generation test performed after the administration of 0.1 U/kg/day s.c each evening for 4 days. As expected the patient had lower baseline IGF-I and IGFBP3 with high insulin and leptin levels. After IGF-I generation test, IGF-I, IGFBP3 and insulin levels increases without changes in body composition and leptin levels.

In the current study, high leptin baseline levels may reflect the hyperinsulinism action over the adipose tissue in MyD and the effect of hypopituitarism over leptin regulation. After 4 days of GH administration, we demonstrated the lack of a modulatory role on leptin levels of GH and acute insulin increase, and a direct effect of GH on leptin can be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhang Y, Proenca R, Maffei, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature 1990;372:425-432.

    Google Scholar 

  2. Considine R, Sinha MK, Heiman M, et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996;334:292-295.

    Google Scholar 

  3. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in human. Diabetes 1996;45:984-987.

    Google Scholar 

  4. Caro JF, Sinha MK, Kolaczynsky JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996;45:1455-1462.

    Google Scholar 

  5. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45:988-991.

    Google Scholar 

  6. Gill MS, Toogood AA, O'Neill PA et al. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol (Oxf) 1997;47:161-167.

    Google Scholar 

  7. Livingston JN, Moxley III RT. Myotonic dystrophy. Phenotype-genotype and insulin resistance. Diab Rev 1994; 2:29-42.

    Google Scholar 

  8. Gómez JM, Molina A, Fernández-Castañer M, Casamitjana R, Martínez-Matos JA, Soler J. Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy disease. Clin Endocrinol (Oxf) (in press).

  9. Moxley RT, Griggs RC, Goldblatt D. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest 1978;62:857-867.

    Google Scholar 

  10. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997;82:654-657.

    Google Scholar 

  11. Janssen YJH, Frölich M, Deurenberg P, Roelfsema F. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. Eur J Endocrinol 1997;137: 650-654.

    Google Scholar 

  12. Nyström F, Ekman B, Österlund M, Lindström T, Öhman KP, Arnqvist HJ. Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment. Clin Endocrinol (Oxf) 1997;47:191-198.

    Google Scholar 

  13. Al-Shoumer KAS, Anyaoku V, Richmond W, Johnston DG. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1997;47: 153-159.

    Google Scholar 

  14. Flokowsky CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA, Donald RA. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1997;45:769-773.

    Google Scholar 

  15. Gómez Sáez JM, Fernández Real JM, Navarro MA, Martínez Matos JA, Soler J. GH secretion status in myotonic dystrophy. Psychoneuroendocrinology 1993;18:183-190.

    Google Scholar 

  16. Gómez Sáez JM, Fernández Real JM, Fernández Castañer M, Navarro Moreno MA, Martinez Matos JA, Soler Ramón J. Study on growth hormone and insulin secretion in myotonic dystrophy. J Mol Med 1994;72:508-511.

    Google Scholar 

  17. Kousta E, Chrisoulidou A, Lawrence NJ et al. The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 1998;48: 685-690.

    Google Scholar 

  18. Kolaczynski JW, Nice MR, Considine RV et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996;45:699-701.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology and Neurology* Services. Ciudad Sanitaria y, Universitaria de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain

    José Manuel Gómez* & Juan Antonio Martínez-Matos

Authors
  1. José Manuel Gómez*
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Antonio Martínez-Matos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez*, J.M., Martínez-Matos, J.A. Leptin after IGF-I Generation Test in a Patient with Hypopituitarism and Myotonic Dystrophy Disease. Pituitary 1, 121–123 (1999). https://doi.org/10.1023/A:1009984505312

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009984505312

Search

Navigation